Overview

Ranibizumab Treatment for Age-Related Macular Degeneretion

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To establish the correlation between visual acuity improvement and QOL measurement after ranibizumab treatment for AMD patients.
Phase:
N/A
Details
Lead Sponsor:
Kyushu University
Collaborators:
Clinical Research Support Center Kyush
Fukuoka University
Kurume University
Novartis
University of Occupational and Environmental Health
Treatments:
Ranibizumab